David M. Tehrani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David M. Tehrani has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Susan S. Huang
Division of Infectious Disease and Health Policy Research Institute, University of California Irvine School of Medicine
3 shared publicationsChenghua Cao
Division of Infectious Disease and Health Policy Research Institute, University of California Irvine School of Medicine
2 shared publicationsHomin Kwark
Division of Infectious Disease and Health Policy Research Institute, University of California Irvine School of Medicine
2 shared publicationsRupak Datta
Division of Infectious Disease and Health Policy Research Institute, University of California Irvine School of Medicine
2 shared publicationsAmy Nichols
University of California San Francisco Medical Center
1 shared publicationCatherine Liu
University of California San Francisco
1 shared publication
Latest Publications
- 1 October 2014
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 35 (10) , 1263-1270
Substantial Shifts in Ranking of California Hospitals by Hospital-Associated Methicillin-ResistantStaphylococcus aureusInfection Following Adjustment for Hospital Characteristics and Case Mix
Substantial Shifts in Ranking of California Hospitals by Hospital-Associated Methicillin-Resistant Staphylococcus aureus Infection Following Adjustment for Hospital Characteristics and Case Mix - Volume 35 Issue 10 - David M. Tehrani, Michael J. Phelan, Chenghua Cao, John Billimek, Rupak Datta, Hoanglong Nguyen, Homin Kwark, Susan S. Huang
- 1 October 2014
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 35 (10) , 1263-1270
Substantial Shifts in Ranking of California Hospitals by Hospital-Associated Methicillin-ResistantStaphylococcus aureusInfection Following Adjustment for Hospital Characteristics and Case Mix
Substantial Shifts in Ranking of California Hospitals by Hospital-Associated Methicillin-Resistant Staphylococcus aureus Infection Following Adjustment for Hospital Characteristics and Case Mix - Volume 35 Issue 10 - David M. Tehrani, Michael J. Phelan, Chenghua Cao, John Billimek, Rupak Datta, Hoanglong Nguyen, Homin Kwark, Susan S. Huang
- 1 November 2013
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 34 (11) , 1218-1221
Estimated Burden of Methicillin-Resistant Staphylococcus aureus in California Hospitals after Changes to Administrative Codes, 2005–2010
We assess the impact of revised International Classification of Diseases, Ninth Revision, codes on methicillin-resistant Staphylococcus aureus burden in California hospitals. Codes were rapidly adopted, demonstrating new capture of colonization and continued relatively stable capture of infections. Nevertheless, despite new colonization codes, coded data demonstrated poor retention between serial hospitalizations.
- 1 November 2013
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 34 (11) , 1218-1221
Estimated Burden of Methicillin-Resistant Staphylococcus aureus in California Hospitals after Changes to Administrative Codes, 2005–2010
We assess the impact of revised International Classification of Diseases, Ninth Revision, codes on methicillin-resistant Staphylococcus aureus burden in California hospitals. Codes were rapidly adopted, demonstrating new capture of colonization and continued relatively stable capture of infections. Nevertheless, despite new colonization codes, coded data demonstrated poor retention between serial hospitalizations.
- 1 February 2013
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 34 (2) , 176-183
Discord among Performance Measures for Central Line—Associated Bloodstream Infection
Background.: Central line-associated bloodstream infection (CLABSI) is a national target for mandatory reporting and a Centers for Medicare and Medicaid Services target for value-based purchasing. Differences in chart review versus claims-based metrics used by national agencies and groups raise concerns about the validity of these measures.Objective.: Evaluate consistency and reasons for discordance among chart review and claims-based CLABSI events.Methods.: We conducted 2 multicenter retrospective cohort studies within 6 academic institutions. A total of 150 consecutive patients were identified with CLABSI on the basis of National Healthcare Safety Network (NHSN) criteria (NHSN cohort), and an additional 150 consecutive patients were identified with CLABSI on the basis of claims codes (claims cohort). Ail events had full-text medical record reviews and were identified as concordant or discordant with the other metric.Results.: In the NHSN cohort, there were 152 CLABSIs among 150 patients, and 73.0% of these cases were discordant with claims data. Common reasons for the lack of associated claims codes included coding omission and lack of physician documentation of bacteremia cause. In the claims cohort, there were 150 CLABSIs among 150 patients, and 65.3% of these cases were discordant with NHSN criteria. Common reasons for the lack of NHSN reporting were identification of non-CLABSI with bacteremia meeting Centers for Disease Control and Prevention (CDC) criteria for an alternative infection source.Conclusion.: Substantial discordance between NHSN and claims-based CLABSI indicators persists. Compared with standardized CDC chart review criteria, claims data often had both coding omissions and misclassification of non-CLABSI infections as CLABSI. Additionally, claims did not identify any additional CLABSIs for CDC reporting. NHSN criteria are a more consistent interhospital standard for CLABSI reporting.
- 1 February 2013
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 34 (2) , 176-183
Discord among Performance Measures for Central Line—Associated Bloodstream Infection
Background.: Central line-associated bloodstream infection (CLABSI) is a national target for mandatory reporting and a Centers for Medicare and Medicaid Services target for value-based purchasing. Differences in chart review versus claims-based metrics used by national agencies and groups raise concerns about the validity of these measures.Objective.: Evaluate consistency and reasons for discordance among chart review and claims-based CLABSI events.Methods.: We conducted 2 multicenter retrospective cohort studies within 6 academic institutions. A total of 150 consecutive patients were identified with CLABSI on the basis of National Healthcare Safety Network (NHSN) criteria (NHSN cohort), and an additional 150 consecutive patients were identified with CLABSI on the basis of claims codes (claims cohort). Ail events had full-text medical record reviews and were identified as concordant or discordant with the other metric.Results.: In the NHSN cohort, there were 152 CLABSIs among 150 patients, and 73.0% of these cases were discordant with claims data. Common reasons for the lack of associated claims codes included coding omission and lack of physician documentation of bacteremia cause. In the claims cohort, there were 150 CLABSIs among 150 patients, and 65.3% of these cases were discordant with NHSN criteria. Common reasons for the lack of NHSN reporting were identification of non-CLABSI with bacteremia meeting Centers for Disease Control and Prevention (CDC) criteria for an alternative infection source.Conclusion.: Substantial discordance between NHSN and claims-based CLABSI indicators persists. Compared with standardized CDC chart review criteria, claims data often had both coding omissions and misclassification of non-CLABSI infections as CLABSI. Additionally, claims did not identify any additional CLABSIs for CDC reporting. NHSN criteria are a more consistent interhospital standard for CLABSI reporting.